First Time Loading...

ARS Pharmaceuticals Inc
NASDAQ:SPRY

Watchlist Manager
ARS Pharmaceuticals Inc Logo
ARS Pharmaceuticals Inc
NASDAQ:SPRY
Watchlist
Price: 8.88 USD -0.34% Market Closed
Updated: Jun 1, 2024

ARS Pharmaceuticals Inc
Selling, General & Administrative

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

ARS Pharmaceuticals Inc
Selling, General & Administrative Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Selling, General & Administrative Analysis
Latest Figures & CAGR of Competitors

Company Selling, General & Administrative CAGR 3Y CAGR 5Y CAGR 10Y
ARS Pharmaceuticals Inc
NASDAQ:SPRY
Selling, General & Administrative
-$47.3m
CAGR 3-Years
-78%
CAGR 5-Years
-68%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Selling, General & Administrative
-$13B
CAGR 3-Years
-2%
CAGR 5-Years
-12%
CAGR 10-Years
-9%
Gilead Sciences Inc
NASDAQ:GILD
Selling, General & Administrative
-$6.1B
CAGR 3-Years
-6%
CAGR 5-Years
-8%
CAGR 10-Years
-13%
Amgen Inc
NASDAQ:AMGN
Selling, General & Administrative
-$6.7B
CAGR 3-Years
-6%
CAGR 5-Years
-5%
CAGR 10-Years
-3%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Selling, General & Administrative
-$1.2B
CAGR 3-Years
-17%
CAGR 5-Years
-17%
CAGR 10-Years
-14%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Selling, General & Administrative
-$2.7B
CAGR 3-Years
-25%
CAGR 5-Years
-12%
CAGR 10-Years
-23%

See Also

What is ARS Pharmaceuticals Inc's Selling, General & Administrative?
Selling, General & Administrative
-47.3m USD

Based on the financial report for Dec 31, 2023, ARS Pharmaceuticals Inc's Selling, General & Administrative amounts to -47.3m USD.

What is ARS Pharmaceuticals Inc's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 5Y
-68%

Over the last year, the Selling, General & Administrative growth was -156%. The average annual Selling, General & Administrative growth rates for ARS Pharmaceuticals Inc have been -78% over the past three years , -68% over the past five years .